Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated（CORT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cort · 股价预测 · 26 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 26 位华尔街分析师
Buy
26 位分析师
共识
评级分布
12 个月目标价
High
$135
Consensus
$83.00
+14.3% upside
Low
$30.00
Median: $91.5 · Last Close: $72.62
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$83.00
14.3% upside
High Target
$135
85.9%
Low Target
$30
-58.7%
Current Price
$72.62
as of today
Based on analyst price targets, the CORT stock price prediction for the next 12 months ranges from $30 to $135. The consensus CORT price forecast of $83.00 implies 14.3% upside from the current price of $72.62.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $76.25 | ↑ 5.00% |
1-day model range: $75.47–$77.03. Peak: $77.03 (+5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CORT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-13 | UBS | Upgrade ↑ | Neutral→Buy |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-01 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-26 | Wolfe Research | Upgrade ↑ | Underperform→Peer Perform |
| 2026-03-26 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Corcept Therapeutics Incorporated (CORT) stock. Of the recent 114 rating actions, 6 were upgrades and 18 were downgrades. 26 analysts currently cover CORT.
分析师推荐趋势
CORT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 5 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$977M
↓ 49.0% YoY
Revenue Next Year
$1.4B
↑ 40.1% YoY
EPS This Year
$0.59
EPS Next Year
$2.61
↑ 346.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CORT EPS of $0.59 for the current fiscal year, based on estimates from 4 analysts. The CORT revenue forecast is $977M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CORT 股价预测由两类独立数据源支撑：来自 26 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CORT 的共识目标价为 $83.00（+14.3% 上行空间），分析师共识为 Buy。
CORT 的短期预测（明日）为 $76.25（+5.00%）。
Corcept Therapeutics Incorporated 在 NASDAQ 上市，代码 CORT。CORT 在 2027 年的整体展望偏积极，在覆盖分析师中约 54% 对应 Buy 共识。
常见问题
CORT 预测 · 8 个问题根据 26 位华尔街分析师，CORT 的 12 个月平均目标价为 $83.00，最高 $135.00、最低 $30.00。若有图表，中位目标价可在上方查看。相对当前价 $72.62，隐含约 +14.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.